Thirty-three patients with acute leukemia (15 with lymphoblastic leukemia and 18 with myeloblastic leukemia) were entered into a program of high-dose radiochemotherapy followed by allogeneic bone-marrow transplantation. These patients were in various clinical stages of disease. Of 10 in complete hematologic remission at the time of transplantation, seven were alive without maintenance therapy at the time of evaluation, eight to 35 months after grafting; one was in relapse. Of 11 who received transplants during partial remission, six were in remission without further treatment eight to 33 months after transplantation. In 12 the disease was refractory to chemotherapy when preparation for transplantation was started, and only one of them was alive and free of disease after 10 months. Recurrent leukemia, graft-versus-host disease, viral pneumonia, and early therapy-related toxicity were the major causes of failure. High-dose chemotherapy and total-body irradiation followed by allogeneic marrow transplantation performed during complete or partial remission can produce long-term remission of acute leukemia.
This article has been cited by other articles:
Grewal, S. S., Barker, J. N., Davies, S. M., Wagner, J. E.
(2003). Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?. Blood
101: 4233-4244
[Full Text]
Petersdorf, E. W., Kollman, C., Hurley, C. K., Dupont, B., Nademanee, A., Begovich, A. B., Weisdorf, D., McGlave, P.
(2001). Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. Blood
98: 2922-2929
[Abstract][Full Text]
Petersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., Hansen, J. A.
(1998). Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and Recipient. Blood
92: 3515-3520
[Abstract][Full Text]
Armitage, J. O.
(1994). Bone Marrow Transplantation. NEJM
330: 827-838
[Full Text]
Jabs, D. A., Wingard, J., Green, W. R., Farmer, E. R., Vogelsang, G., Saral, R.
(1989). The Eye in Bone Marrow Transplantation: III. Conjunctival Graft-vs-Host Disease. Arch Ophthalmol
107: 1343-1348
[Abstract]
Hood, A. F., Vogelsang, G. B., Black, L. P., Farmer, E. R., Santos, G. W.
(1987). Acute Graft-vs-Host Disease: Development Following Autologous and Syngeneic Bone Marrow Transplantation. Arch Dermatol
123: 745-750
[Abstract]
Bortin, M. M., Gale, R. P., Kay, H. E. M., Rimm, A. A.
(1983). Bone Marrow Transplantation for Acute Myelogenous Leukemia: Factors Associated With Early Mortality. JAMA
249: 1166-1175
[Abstract]
BEUTLER, E., BLUME, K. G.
(1980). Marrow Transplantation and Acute Nonlymphocytic Leukemia. ANN INTERN MED
93: 778-780
[Abstract]
